Novartis is a Swiss medicines company headquartered in Basel. Novartis AG was incorporated in 1996, and the Sandoz generics business was spun off in 2023.
It had about 75,300 full-time employees and USD 54.5 billion net sales in 2025.
Founded 1996Head office Basel, SwitzerlandStaff ~75,300 FTE (2025)Revenue ~$54.5B net sales (FY2025)Website ↗
Novartis cut its emissions to 4.36 MtCO2e in 2025, with Scope 1 and 2 down 45% and Scope 3 down 17% against 2022, under SBTi-validated targets for net zero by 2040. Its electricity is 100% renewable, though only 49% of all its energy is. Its waste rose in 2025, its 'carbon neutral' claim rests on removal credits and certificates, and old chemical landfills near Basel are still being cleaned up.
Novartis scores 52/100 (Making progress) on SINK's independent climate assessment, scored from public data only. Scores are free. Companies can never pay for anything about their own score. Last verified October 2026.
That places Novartis joint 110th of 934 companies scored, and 2nd of 22 in Healthcare / Pharmaceuticals.
Strongest on Carbon Footprint: Operations and Carbon Footprint: Supply Chain (9/10, 9/10). Weakest on Nature & Biodiversity Impact and Resource Use & Waste (5/10, 5/10).
For each question that lost points, the evidence our public rubric looks for that we didn't find.
A score changes when the evidence does. We use new published evidence at the next rescore. Anyone can send us new evidence, free. How to send it.
Same ten questions for every company. No private weighting.
SINK = (0.3 × Base + 0.7 × Performance) × ScaleNovartis's score has moved from 50 to 52 across 3 recorded reviews, up 2 points.
Europe RE100 re-score under v2.5.21 (owner rulings 2026-10-28)
Bio correction, score unchanged. Headquarters "Prague, Czech Republic" -> "Basel, Switzerland" per the Novartis AG Form 20-F for FY2025 cover page (principal executive offices: Lichtstrasse 35, 4056 Basel; https://www.sec.gov/Archives/edgar/data/0001114448/000111444826000004/nvs-20251231.htm).
Initial score at platform launch
13 sources used in this assessment. All publicly available. Each row shows which of the ten questions it informed.
46% of them were published by Novartis itself; the rest come from independent sources.
7 of 13 sources are independent of the company.
“Gross Scope 1 GHG emissions 198.4 210.6”
“KPMG AG has provided limited assurance in accordance”
“Assess the impact on nature at Novartis sites close to nature-sensitive areas”
“have been validated by the Science Based Targets initiative (SBTi)”
“Novartis discloses the global total of fees related to membership fees paid to trade associations”
“adding more than 275 megawatts of clean power”
“collectively add more than 275 megawatts of clean power to the electrical grid”
“implemented on-site solar panels generating 3,000 megawatt-hours annually”
“Novartis does not publicly disclose audit results containing antibacterial discharge levels”
“reflecting an A rating in both CDP Climate Change and CDP Water Security in 2024”
“Konkret düften Novartis, BASF und Syngenta 50 Millionen zahlen”
“Damit dürfte sich die Sanierung des mit Lindan belasteten Geländes um ein weiteres halbes Jahr verzögern”
“has transitioned to 100 percent renewable electricity across its global operations under its RE100 commitment”
If you believe a source has been misread or a newer version exists, submit a challenge.
Use this score in tenders
Send the link, or the one-page score sheet. It links back to this page and every source. Free.
Open the score sheet →Send new evidence, free
Scored low because little is published? Publish what you do and send us the link, free. If it holds up, your score changes, and the change is logged on your page.
How to send evidence →Put your score on your website, free
It shows the current score and links to this page, so it changes when the score does.
Track this score
Bidding for a public contract? Check if you need a Carbon Reduction Plan, free →
Free, independent, every source shown. Send it to any buyer who asks about your sustainability.
Where Novartis sits among healthcare / pharmaceuticals peers.
Among the 22 major healthcare / pharmaceuticals brands we've scored, Novartis sits 2nd of 22.
The one company in the sector scoring above Novartis.
See the full Healthcare / Pharmaceuticals table →One email, every Sunday. Score changes, new research, the stories behind the numbers. Free.
We'll send one email to confirm. No spam. Unsubscribe in one click.
Checking a company?
Search free →Asked to prove you're sustainable?
Get your business scored, free →Been scored?
Find your page and claim it, free →Scores are free. Companies can never pay for anything about their own score.